Bacterial cell wall components as immunomodulators - II. The bacterial cell wall extract OM-85 BV as unspecific activator, immunogen and adjuvant in mice

International Journal of Immunopharmacology

Volumn 19, Issue 9-10, 1997, Pages 551-558

  Bessler, W G ^a   Huber, M ^a   Baier, W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adjuvant; Bacterial cell wall; Immunomodulation; Respiratory tract infections; Vaccination

Indexed keywords

ANTIGEN; BACTERIUM LYSATE; BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGICAL ADJUVANT; IMMUNOMODULATING AGENT; IMOCUR; INFLUENZA VACCINE; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; LIPOPROTEIN; NITRITE; PEPTIDOGLYCAN; PICRIC ACID; PORIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; B LYMPHOCYTE ACTIVATION; BACTERIAL CELL WALL; CONFERENCE PAPER; CONTROLLED STUDY; IMMUNOGENICITY; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BACTERIA; CELL EXTRACTS; CELL WALL; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, NUDE;

EID: 0031224945     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(97)00055-6     Document Type: Conference Paper

References (16)

1. Bessler, W. G., Kleine, B., Martinez-Alonso, C., Biesert, L., Strecker, M., Wiesmüller, K.-H., Metzger, J. and Jung, G. (1990) Biological activity of bacterial surface components : bacterial extracts and defined bacterial cell wall components as immunomodulators. Lung 168, 707-715.
2. Bessler, W. G., Beck, P., Konetznick, U., Loleit, M., Sedelmeier, E., Hoffmann, P., Strecker, M. and Stöcklin, S. (1991) Biological activity of bacterial surface components. Immunogenicity and immunomodulatory properties of a bacterial extract. Arzneim.-Forsch./ Drug Res. 41(1), 274-279.
3. Bessler, W. G. and Sedelmeier, E. (1993) Biological activity of bacterial cell wall components. Immunogenicity of an immunostimulating bacterial extract. Arzneim.-Forsch./ Drug Res. 43(1), 502-507.
4. Brandtzaeg, P., Berstad, A. E., Farstad, I. N., Haraldsen, G., Hetgeland, L., Jahnsen, F. L., Johansen, F.-E., Natvig, I. B., Nilsen, E. M. and Rugtveit, J. (1997) Mucosal Immunity - A Major Adaptive Defence Mechanism. Behring Inst. Mitt. 98, 1-23.
5. Duchow, J., Marchant, A., Delville, J. P., Schandene, L. and Goldman, M. (1992) Upregulation of adhesion molecules induced by Broncho-Vaxom on phagocytic cells. Int. J. Immunopharmac. 14, 761-766.
6. Hauschildt, S., Bassenge, E., Bessler, W., Busse, R. and Mülsch, A. (1990) L-arginine-dependent nitric oxide formation and nitrite release in bone marrow-derived macrophages stimulated with bacterial lipopeptide and lipopolysaccharide. Immunol. 70, 332-337.
7. Heintz, B., Schlenter, W. W., Kirsten, R. and Nelson, K. (1989) Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis - a multicentric, placebo-controlled, doubleblind study. Int. J. Clin. Pharm. Ther. Toxicology 27, 530-534.
8. Jahn, S., Schwab, J., Kiessig, S, T., Lukowsky, A., Huhnholtz, K., Mehl, M., Specht, U., Grunow, R., V. and Baeher, R. (1989) Occurrence of hybridomas producing multispecific IgM in human × (human-mouse) fusions with lymphocytes from different human immune compartments. Immunol. 35, 271.
9. Keller, R. and Hinz, G. (1984) Die Wirkung eines oralen polyvaleten Bakterienlysates (Bronocho-Vaxom®) bei chronischer Bronchitis. Prox. Klin. Pneumol. 38, 225-228.
10. Mauel, J., Van Pham, T., Kreis, B. and Bauer, J. (1989) Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages. Int. J. Immunopharmacol. 11, 637-645.
11. Mims, C. A. (1976) The Pathogenesis of Infectious Disease. Academic Press, London.
12. Nauck, M., Matthys, H., Emmons, L. R., Perruchoud, A., Reichel, H., Pfleger, S., Breyer, S. and Paupe, J. (1991a) Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections. Respiration 58, 150-154.
13. Nauck, M., Matthys, H., Emmons, L. R., Perruchoud, A., Reichel, H., Pfleger, S., Breyer, S., Roedler, S., Georgopoulus A. and Block, L. H. (1991b) The immunomodulators Broncho-Vaxom and Uro-Vaxom stimulate the bacterial killing and oxidative metabolism of polymorphonuclear leukocytes by the activation of phosphatidylinositol turnover. Int. J. Exp. Clin.Chemoth. 4, 1-11.
14. Schlecht, S., Wiesmüller, K.-H., Jung, G. and Bessler, W. G. (1989) Enhancement of protection against Salmonella infection in mice mediated by a synthetic lipopeptide analogue of bacterial lipoprotein in Salmonella typhimurium vaccines. Zbl. Bakt. 271, 493-500.
15. Wiesmüller, K.-J., Bessler, W. G. and Jung, G. (1983) Synthesis of the mitogenic S-[2,3-Bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escericha coli lipoprotein. Hoppe-Seyler's Z. Physiol. Chem. 364, 593-606.
16. Wybran, J., Libin, M. and Schandene, L. (1989) Activation of natural killer cells and cytokine production in man by bacterial extracts. Immunopharmacol. Immunotoxicol. 11, 17-32.